Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury
- 1 July 2006
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 21 (7) , 989-994
- https://doi.org/10.1007/s00467-006-0146-y
Abstract
Background: Diarrhea-associated hemolytic uremic syndrome (D+HUS) causes acute renal failure. Neutrophil gelatinase-associated lipocalcin (NGAL) is an early indicator of kidney injury. Objective: To determine if urinary NGAL excretion is a biomarker of severe renal injury and predicts the need for dialysis in D+HUS. Methods: Patients were randomly selected from among participants in the SYNSORB Pk trial. Urine samples were collected daily if available during the first week of hospitalization. NGAL levels were determined by ELISA. Results: 34 children, age 5.9±3.9 yr, were studied; ten (29%) required dialysis. Patients were categorized based on urinary NGAL concentration within five days of hospitalization - PP=0.024) compared to children with normal excretion. Conclusion: The majority of patients with D+HUS have renal tubular epithelial injury, as evidenced by elevated urinary NGAL excretion. Urinary NGAL levels below 200 ng/ml within five days of hospitalization may be an adjunctive marker that defines less severe renal involvement.Keywords
This publication has 22 references indexed in Scilit:
- Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxinKidney International, 2005
- Acute renal failureThe Lancet, 2005
- Acute renal failureThe Lancet, 2005
- Amelioration of Ischemic Acute Renal Injury by Neutrophil Gelatinase-Associated LipocalinJournal of the American Society of Nephrology, 2004
- Identification of Neutrophil Gelatinase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal InjuryJournal of the American Society of Nephrology, 2003
- Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapyPediatric Nephrology, 2002
- Pathogenesis, treatment, and therapeutic trials in hemolytic uremic sydromeCurrent Opinion in Pediatrics, 1999
- Cytotoxic effect of Shiga toxin-1 on human proximal tubule cellsKidney International, 1998
- Management of patients with hemolytic uremic syndrome demonstrating severe azotemia but not anuriaPediatric Nephrology, 1996
- Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndromeThe Journal of Pediatrics, 1994